$DNMR
Danimer Scientific, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023063782 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $10.95M $10.95M $10.45M
YoY Change -28.58% 4.79% -21.85%
Cost Of Revenue $16.60M $18.69M $14.50M
YoY Change -21.34% 28.84% 6.63%
Gross Profit -$5.657M -$7.737M -$4.055M
YoY Change -2.18% 90.8% 1647.84%
Gross Profit Margin -51.69% -70.67% -38.81%
Selling, General & Admin $17.28M $16.56M $19.41M
YoY Change -2.04% -14.72% -27.0%
% of Gross Profit
Research & Development $5.676M $6.883M $7.947M
YoY Change 59.75% -13.39% 58.62%
% of Gross Profit
Depreciation & Amortization $7.367M $7.260M $4.584M
YoY Change 1.18% 58.38% 44.24%
% of Gross Profit
Operating Expenses $25.17M $23.44M $27.36M
YoY Change 5.18% -14.33% -13.42%
Operating Profit -$30.83M -$31.24M -$94.91M
YoY Change 3.75% -67.08% 198.13%
Interest Expense -$8.401M -$8.450M $553.0K
YoY Change -785.24% -1628.03% 124.8%
% of Operating Profit
Other Income/Expense, Net $1.000K -$8.452M -$206.0K
YoY Change -99.75% 4002.91% -100.73%
Pretax Income -$39.43M -$39.69M -$95.11M
YoY Change 40.36% -58.27% 2543.47%
Income Tax $2.000K $500.0K -$236.0K
% Of Pretax Income
Net Earnings -$39.43M -$40.16M -$94.88M
YoY Change 40.58% -57.67% -1312.47%
Net Earnings / Revenue -360.29% -366.82% -908.08%
Basic Earnings Per Share -$0.39 -$0.94
Diluted Earnings Per Share -$0.39 -$0.39 -$937.5K
COMMON SHARES
Basic Shares Outstanding 102.0M 102.0M 101.2M
Diluted Shares Outstanding 102.0M 101.2M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.17M $77.40M $99.13M
YoY Change -5.77% -21.92% -48.96%
Cash & Equivalents $59.17M $77.39M $99.13M
Short-Term Investments
Other Short-Term Assets $4.714M $4.800M $5.080M
YoY Change -9.78% -5.51% 42.98%
Inventory $25.27M $26.69M $35.20M
Prepaid Expenses $4.714M $4.754M $5.080M
Receivables $18.23M $12.42M $17.43M
Other Receivables $652.0K $700.0K $1.377M
Total Short-Term Assets $108.0M $127.1M $162.6M
YoY Change -13.62% -21.85% -31.93%
LONG-TERM ASSETS
Property, Plant & Equipment $464.3M $449.8M $436.9M
YoY Change 2.28% 2.96% 96.32%
Goodwill $0.00
YoY Change -100.0%
Intangibles $77.79M $78.66M $81.49M
YoY Change -3.89% -3.47% -5.97%
Long-Term Investments
YoY Change
Other Assets $16.54M $346.0K $227.0K
YoY Change 7220.35% 52.42% 55.48%
Total Long-Term Assets $590.1M $593.9M $570.8M
YoY Change 0.49% 4.05% 38.75%
TOTAL ASSETS
Total Short-Term Assets $108.0M $127.1M $162.6M
Total Long-Term Assets $590.1M $593.9M $570.8M
Total Assets $698.1M $721.0M $733.4M
YoY Change -1.99% -1.69% 12.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.292M $3.909M $4.324M
YoY Change -64.67% -9.6% -78.78%
Accrued Expenses $7.511M $5.899M $20.41M
YoY Change 50.19% -71.09% 138.37%
Deferred Revenue $1.000M $2.000M
YoY Change 758.37%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.368M $1.184M $1.501M
YoY Change -30.63% -21.12% 349.4%
Total Short-Term Liabilities $15.72M $14.77M $31.57M
YoY Change -37.82% -53.22% -2.73%
LONG-TERM LIABILITIES
Long-Term Debt $381.4M $378.7M $286.0M
YoY Change 33.18% 32.43% 868.2%
Other Long-Term Liabilities $22.95M $1.153M $641.0K
YoY Change 5034.68% 79.88% -40.21%
Total Long-Term Liabilities $404.4M $1.153M $641.0K
YoY Change 90367.11% 79.88% -97.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.72M $14.77M $31.57M
Total Long-Term Liabilities $404.4M $1.153M $641.0K
Total Liabilities $420.1M $416.7M $341.7M
YoY Change 25.53% 21.96% 181.98%
SHAREHOLDERS EQUITY
Retained Earnings -$454.1M -$414.7M -$270.6M
YoY Change 52.06% 53.25% 154.22%
Common Stock $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.0M $304.3M $391.7M
YoY Change
Total Liabilities & Shareholders Equity $698.1M $721.0M $733.4M
YoY Change -1.99% -1.69% 12.78%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$39.43M -$40.16M -$94.88M
YoY Change 40.58% -57.67% -1312.47%
Depreciation, Depletion And Amortization $7.367M $7.260M $4.584M
YoY Change 1.18% 58.38% 44.24%
Cash From Operating Activities -$15.93M -$10.18M -$20.19M
YoY Change 274.48% -49.58% -18.59%
INVESTING ACTIVITIES
Capital Expenditures $1.965M $2.680M -$24.78M
YoY Change -93.63% -110.81% -44.8%
Acquisitions
YoY Change
Other Investing Activities $2.000K $20.00K -$18.04M
YoY Change -100.11% -88.07%
Cash From Investing Activities -$1.963M -$2.660M -$42.82M
YoY Change -93.64% -93.79% -78.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -460.0K -540.0K 22.96M
YoY Change -64.06% -102.35% 7844.98%
NET CHANGE
Cash From Operating Activities -15.93M -10.18M -20.19M
Cash From Investing Activities -1.963M -2.660M -42.82M
Cash From Financing Activities -460.0K -540.0K 22.96M
Net Change In Cash -18.36M -13.38M -40.05M
YoY Change -49.55% -66.59% -81.84%
FREE CASH FLOW
Cash From Operating Activities -$15.93M -$10.18M -$20.19M
Capital Expenditures $1.965M $2.680M -$24.78M
Free Cash Flow -$17.90M -$12.86M $4.593M
YoY Change -49.02% -379.99% -77.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001779020
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39280
dei Entity Registrant Name
EntityRegistrantName
DANIMER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1924518
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Industrial Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
39817
dei City Area Code
CityAreaCode
229
dei Local Phone Number
LocalPhoneNumber
243-7075
dei Security12b Title
Security12bTitle
Class A Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
DNMR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102035267
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77393000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62792000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12422000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17989000
CY2023Q3 us-gaap Other Receivables
OtherReceivables
715000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1635000
CY2023Q3 us-gaap Inventory Net
InventoryNet
26685000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4754000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5225000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5103000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4687000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
127072000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
125071000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449824000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78660000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19157000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19028000
CY2023Q3 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2022Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14461000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1609000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
346000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
226000
CY2023Q3 us-gaap Assets
Assets
720966000
CY2022Q4 us-gaap Assets
Assets
712270000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3909000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14977000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5899000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
438000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
0
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1184000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14767000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25287000
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
113000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
212000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21965000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22114000
CY2023Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
378687000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
286398000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
200000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1153000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
447000
CY2023Q3 us-gaap Liabilities
Liabilities
416685000
CY2022Q4 us-gaap Liabilities
Liabilities
334658000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102035267
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102035267
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101804454
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
718958000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
676250000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-414687000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298648000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
304281000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
377612000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
720966000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
712270000
CY2023Q3 us-gaap Revenues
Revenues
10948000
CY2022Q3 us-gaap Revenues
Revenues
10448000
us-gaap Revenues
Revenues
35739000
us-gaap Revenues
Revenues
37894000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
18685000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
14503000
us-gaap Cost Of Revenue
CostOfRevenue
56327000
us-gaap Cost Of Revenue
CostOfRevenue
45606000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16555000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19413000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52098000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62042000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6883000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7947000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21667000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24469000
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-64000
CY2022Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-234000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1000
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
63491000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
63491000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
42187000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
105354000
us-gaap Costs And Expenses
CostsAndExpenses
130326000
us-gaap Costs And Expenses
CostsAndExpenses
195609000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31239000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-94906000
us-gaap Operating Income Loss
OperatingIncomeLoss
-94587000
us-gaap Operating Income Loss
OperatingIncomeLoss
-157715000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-132000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1607000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-99000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8614000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8584000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-553000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21132000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2197000
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1500000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-102000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1500000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
240000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
324000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8452000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-206000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21135000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5241000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39691000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95112000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115722000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-152474000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
468000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-236000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
317000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-767000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-40159000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-94876000
us-gaap Net Income Loss
NetIncomeLoss
-116039000
us-gaap Net Income Loss
NetIncomeLoss
-151707000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.5
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.5
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102025684
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102025684
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101199195
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101199195
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101953827
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101953827
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100993068
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100993068
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
304281000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
391721000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
304281000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
391721000
us-gaap Profit Loss
ProfitLoss
-116039000
us-gaap Profit Loss
ProfitLoss
-151707000
us-gaap Share Based Compensation
ShareBasedCompensation
42227000
us-gaap Share Based Compensation
ShareBasedCompensation
42398000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
22005000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13172000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6209000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1601000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
1462000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-1205000
dnmr Inventory Reserves
InventoryReserves
540000
dnmr Inventory Reserves
InventoryReserves
609000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-278000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-270000
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-234000
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-199000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-767000
dnmr Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
102000
dnmr Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
1500000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-99000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8614000
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
0
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
-1215000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
63491000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-941000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-43000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7029000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1747000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-555000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2724000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5475000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14271000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1816000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1749000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1244000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2019000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
119000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2061000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4642000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1893000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5037000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
706000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
438000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1786000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31331000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57582000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25722000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133632000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-18037000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25704000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151628000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
130000000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
24700000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33296000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1547000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12437000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
886000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
282000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
526000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
215000
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
0
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
79000
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
0
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
55000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84488000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23032000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
27453000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-186178000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64401000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286968000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91854000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100790000
us-gaap Interest Paid Net
InterestPaidNet
16349000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Operating Lease Payments
OperatingLeasePayments
2787000
us-gaap Operating Lease Payments
OperatingLeasePayments
2657000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2023Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
87300000
CY2023Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
78300000
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
10936000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
19964000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
762000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1524000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14987000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11255000
CY2023Q3 us-gaap Inventory Net
InventoryNet
26685000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q3 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
8800000
CY2022Q4 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
4900000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
500000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
513100000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
498814000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63276000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44865000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449824000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2023Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7253000
CY2022Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4585000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
22005000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13172000
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
208367000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
198545000
CY2023Q3 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14900000
CY2022Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14600000
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3600000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P17Y9M18D
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
95565000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94291000
CY2023Q3 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-2682000
CY2022Q4 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-1604000
CY2023Q3 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92883000
CY2022Q4 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92687000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-13350000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-8585000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-16905000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-13350000
CY2023Q3 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
75978000
CY2022Q4 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
79337000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78660000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2390000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
134000
CY2023Q3 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1352000
CY2022Q4 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1305000
CY2023Q3 dnmr Other Accrued Taxes
OtherAccruedTaxes
1002000
CY2022Q4 dnmr Other Accrued Taxes
OtherAccruedTaxes
669000
CY2023Q3 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
304000
CY2022Q4 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
415000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
286000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
443000
CY2023Q3 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
94000
CY2022Q4 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
1089000
CY2023Q3 dnmr Purchase Accrual
PurchaseAccrual
31000
CY2022Q4 dnmr Purchase Accrual
PurchaseAccrual
401000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
440000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
545000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5899000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0118
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0027
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-800000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0025
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
951000
CY2022Q3 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
875000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
2696000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
2636000
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P16Y
dnmr Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.144
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-05-07
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
417313000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
298317000
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37442000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
9947000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1184000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q3 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
378687000
CY2022Q4 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
286398000
CY2021Q4 dnmr Convertible Senior Notes Due Year
ConvertibleSeniorNotesDueYear
2026
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.79
CY2023Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
45000000
CY2023Q3 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2023Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1900000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0674
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0824
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
598000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
623000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
265000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
261087000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
130034000
CY2023Q3 dnmr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
24706000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
417313000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101114861
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100687820
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
96891
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
273812
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
230813
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
700853
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102035267
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101388673
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102035267
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101388673
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125492
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125492
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42113612
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40889145
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42113612
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40889145
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1100000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3200000
CY2023Q3 us-gaap Revenues
Revenues
10948000
CY2022Q3 us-gaap Revenues
Revenues
10448000
us-gaap Revenues
Revenues
35739000
us-gaap Revenues
Revenues
37894000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14324000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14305000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
42933000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
42550000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11844644
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.23
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
204254
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4667
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12044231
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.04
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M23D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
852617000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
93633
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11950598
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.02
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M19D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
50150
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11900448
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M15D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5217843
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y29D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q3 dnmr Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest
11900448
CY2023Q3 dnmr Weighted Average Exercise Price Vested And Expected To Vest
WeightedAverageExercisePriceVestedAndExpectedToVest
14.02
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y11M15D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.97
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
17800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
dnmr Royalty Per Share
RoyaltyPerShare
0.05
dnmr Weights Of Pha Sold
WeightsOfPhaSold
500000000
dnmr Decrease Royalty Per Share
DecreaseRoyaltyPerShare
0.025
dnmr Prepaid Royalties Loss On Forfeiture
PrepaidRoyaltiesLossOnForfeiture
500

Files In Submission

Name View Source Status
0000950170-23-063782-index-headers.html Edgar Link pending
0000950170-23-063782-index.html Edgar Link pending
0000950170-23-063782.txt Edgar Link pending
0000950170-23-063782-xbrl.zip Edgar Link pending
dnmr-20230930.htm Edgar Link pending
dnmr-20230930.xsd Edgar Link pending
dnmr-ex31_1.htm Edgar Link pending
dnmr-ex31_2.htm Edgar Link pending
dnmr-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
dnmr-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dnmr-20230930_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dnmr-20230930_def.xml Edgar Link unprocessable
dnmr-20230930_lab.xml Edgar Link unprocessable
dnmr-20230930_cal.xml Edgar Link unprocessable